An Open-label Extension Study To Evaluate Safety Of PF-06252616 in Boys With Duchenne Muscular Dystrophy
A Multicenter, Open-Label Extension Study to Evaluate the Long Term Safety of PF-06252616 in Boys With Duchenne Muscular Dystrophy
Category & Conditions: Rare Diseases
Medicine: Domagrozumab (PF-06252616)
ClinicalTrials.gov Identifier (NCT): NCT02907619
Protocol ID: B5161004
PrintDownloadOpen Plain Language Summary Result: Click here